Premium
H ‐coil repetitive transcranial magnetic stimulation for pain relief in patients with diabetic neuropathy
Author(s) -
Onesti E.,
Gabriele M.,
Cambieri C.,
Ceccanti M.,
Raccah R.,
Di Stefano G.,
Biasiotta A.,
Truini A.,
Zangen A.,
Inghilleri M.
Publication year - 2013
Publication title -
european journal of pain
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.305
H-Index - 109
eISSN - 1532-2149
pISSN - 1090-3801
DOI - 10.1002/j.1532-2149.2013.00320.x
Subject(s) - transcranial magnetic stimulation , medicine , stimulation , anesthesia , nociception , motor cortex , analgesic , diabetic neuropathy , crossover study , reflex , neuropathic pain , neuroplasticity , visual analogue scale , psychology , physical medicine and rehabilitation , neuroscience , diabetes mellitus , placebo , endocrinology , receptor , alternative medicine , pathology
Background Painful neuropathy is associated with plasticity changes in the nervous system. Standard repetitive transcranial magnetic stimulation ( rTMS ) is a non‐invasive technique used to study changes in cortical excitability and to inhibit pain perception. Deep rTMS is a newer development that allows direct activation of deeper neuronal populations, by a unique coil design termed the H ‐coil. This study was designed to assess whether deep rTMS applied over the motor cortical lower‐limb representation relieves pain in patients with diabetic neuropathy. Methods Patients were randomly assigned to receive daily real or sham H ‐coil rTMS for 5 consecutive days. After a 5‐week washout period, they crossed over to the alternative treatment for additional 5 days (according to a crossover study design). Outcome measures were changes in the visual analogue scale ( VAS ) for pain and in area and threshold of RIII nociceptive flexion reflex ( RIII reflex). Results Of the 25 patients randomized, 23 completed the study. After real rTMS , the VAS scores decreased significantly ( p = 0.01), and so did RIII reflex area ( p < 0.01), while no significant effects in these variables were induced by the sham rTMS treatment. The rTMS ‐induced changes in the outcome measures disappeared about 3 weeks after stimulation. All patients tolerated stimulation well. Conclusions Deep H ‐coil rTMS provides pain relief in patients with diabetic neuropathy. This innovative technique can induce a therapeutic effect on brain areas that otherwise remain difficult to target. rTMS may produce its analgesic effects, inducing motor cortex plasticity and activating descending inhibitory pain control systems.